The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2013Neuroprotectin D1 (NPD1) as a Disease-modifying Therapy for Parkinson’s Disease
Objective/Rationale:
Progressive loss of dopaminergic neurons in Parkinson’s disease (PD) involves several pathogenic mechanisms. It may be assumed that drugs acting on more than one... -
Research Grant, 2013Search for Specific Retinal Biomarkers of Parkinson’s Disease
Objective/Rationale:
Although not usually thought of as part of Parkinson’s disease (PD), relatively subtle changes in vision and retinal structure have been reported among PD patients by... -
Rapid Response Innovation Awards, 2013Epigenetics of Parkinson’s Disease in Japanese Males in the Kuakini Honolulu Heart Program
Objective/Rationale:
The goals of the project are to identify a unique set of DNA modifications (methylation) in brain sections of those with and without Parkinson’s disease (PD), exposed to... -
Research Grant, 2013Near Infrared Chronic Intracranial Illumination for Neuroprotection in Parkinson's Disease
Objective/Rationale:
The treatment of Parkinson’s Disease (PD) is based on medication and on surgical procedures. These therapies alleviate symptoms but do not change the evolution of the... -
Rapid Response Innovation Awards, 2013Glycosylation as an Inhibitor of Alpha-synuclein Aggregation
Objective/Rationale:
During the development of Parkinson’s disease the protein alpha-synuclein forms toxic clumps, or aggregates, that have been demonstrated to directly contribute to the... -
Rapid Response Innovation Awards, 2013Investigation of the Contribution of Copy Number Alterations in Parkinson’s Disease Genes to Pathogenesis
Objective/Rationale:
In most cases, the cause of Parkinson’s disease (PD) is unknown. Testing blood for DNA mutations is usually negative, but there is increasing evidence that DNA can...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.